DAC HYP COMPOSITIONS AND METHODS The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof (II71 iY7 (h I'
申请公布号
AU2016202873(A1)
申请公布日期
2016.05.26
申请号
AU20160202873
申请日期
2016.05.04
申请人
ABBVIE BIOTECHNOLOGY LTD
发明人
HARTMAN, TAYMAR;SAUER, PAUL W.;BURKY, JOHN W.;WESSON, MARK C.;HUANG, PING Y.;ROBINSON, THOMAS J.;PARTRIDGE, BRAEDEN;TSO, J. YUN